Hims & Hers Health HIMS
NYSE HIMS
$31.84 +0.75 (+2.41%)
As of: Aug 20, 2026 · 3:59 PM EDT

Hims & Hers Health (HIMS) Share-based Compensation (2020 - 2026)

Hims & Hers Health (HIMS) posted Share-based Compensation of $39.2 million for Q1 2026, down 2.69% sequentially from $40.3 million in Q4 2025, and up 52.49% YoY from $25.7 million in Q1 2025.

Hims & Hers Health (HIMS) Share-based Compensation (2020 - 2026) Analysis & Trends

Hims & Hers Health has reported Share-based Compensation for 7 years, with the latest figure at $39.2 million in Q1 2026.

  • Quarterly Share-based Compensation rose 52.49% year-over-year to $39.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $148.7 million (up 151.33% YoY) and the FY2025 annual result came in at $135.2 million, up 157.6% from the prior year.
  • Share-based Compensation fell to $39.2 million in Q1 2026 per HIMS's latest filing, from $40.3 million in the prior quarter.
  • Over five years, Share-based Compensation peaked at $40.3 million in Q4 2025 and troughed at -$30.4 million in Q3 2023.
  • A 5-year average of $14.7 million and a median of $19.1 million in 2022 frame the typical range for Share-based Compensation.
  • The sharpest annual moves came in 2023 and 2025: Share-based Compensation sank 377.08% in 2023, then soared 973.35% in 2025.
  • Over 5 years, Share-based Compensation stood at -$29.3 million in 2022, then surged by 119.41% to $5.7 million in 2023, then surged by 241.7% to $19.4 million in 2024, then surged by 107.62% to $40.3 million in 2025, then retreated by 2.69% to $39.2 million in 2026.
  • According to Business Quant data, Share-based Compensation over the past three periods registered $39.2 million, $40.3 million, and $34.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Haleon 43.83 Bn 42.86 Bn - -
2 Teva Pharmaceutical Industries 42.87 Bn 39.22 Bn 2.15 Bn 40.00 Mn
3 Zoetis 31.41 Bn 29.73 Bn 1.05 Bn 26.00 Mn
4 Takeda Pharmaceutical 28.55 Bn 22.75 Bn 5.10 Bn 114.12 Mn
5 United Therapeutics 22.08 Bn 19.42 Bn 683.80 Mn 19.00 Mn
6 Viatris 18.73 Bn 17.84 Bn 1.46 Bn 30.40 Mn
7 Neurocrine Biosciences 15.44 Bn 15.05 Bn 935.80 Mn 65.00 Mn
8 Elanco Animal Health 11.75 Bn 11.22 Bn 798.00 Mn 7.00 Mn
9 Dr Reddys Laboratories 10.11 Bn 9.94 Bn - -
10 Hims & Hers Health 7.42 Bn 6.57 Bn 480.80 Mn 39.77 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 39.77 Mn
Jun 30, 2026 39.77 Mn
Mar 31, 2026 39.21 Mn
Mar 31, 2026 39.21 Mn
Dec 31, 2025 40.29 Mn
Dec 31, 2025 40.29 Mn
Sep 30, 2025 34.37 Mn
Sep 30, 2025 34.37 Mn
Jun 30, 2025 34.87 Mn
Jun 30, 2025 34.87 Mn
Mar 31, 2025 25.71 Mn
Mar 31, 2025 25.71 Mn
Dec 31, 2024 19.41 Mn
Dec 31, 2024 19.41 Mn
Sep 30, 2024 10.82 Mn
Sep 30, 2024 10.82 Mn
Jun 30, 2024 3.25 Mn
Jun 30, 2024 3.25 Mn
Mar 31, 2024 19.03 Mn
Mar 31, 2024 19.03 Mn